Dis-Chem Pharmacies (JSE:DCP) Other Current Receivables: R1,817 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:DCP Dis-Chem Pharmacies Ltd JSE:DCP
85 GF Score
Price R32.20
GF Value R38.25
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dis-Chem Pharmacies Other Current Receivables?

Dis-Chem Pharmacies JSE:DCP -0.92% 85 Other Current Receivables is R1,817 Mil as of Feb. 2026. GuruFocus rates JSE:DCP with a GF Score™ of 85/100 and a GF Value™ of R38.25 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Dis-Chem Pharmacies's Other Current Receivables for the quarter that ended in Feb. 2026 was R1,817 Mil.

Dis-Chem Pharmacies's quarterly Other Current Receivables declined from Feb. 2025 (R1,642.62 Mil) to Aug. 2025 (R49.06 Mil) but then increased from Aug. 2025 (R49.06 Mil) to Feb. 2026 (R1,816.51 Mil).

Dis-Chem Pharmacies's annual Other Current Receivables increased from Feb. 2024 (R1,261.55 Mil) to Feb. 2025 (R1,642.62 Mil) and increased from Feb. 2025 (R1,642.62 Mil) to Feb. 2026 (R1,816.51 Mil).


Dis-Chem Pharmacies Other Current Receivables Related Terms


Dis-Chem Pharmacies Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Dis-Chem Pharmacies's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dis-Chem Pharmacies Other Current Receivables Chart

Dis-Chem Pharmacies Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,383.17 1,398.76 1,261.55 1,642.62 1,816.51

Dis-Chem Pharmacies Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,261.55 126.43 1,642.62 49.06 1,816.51
JSE:DCP
85GF Score
Dis-Chem Pharmacies Ltd JSE:DCP
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dis-Chem Pharmacies Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of R1,817 Mil mean?
Dis-Chem Pharmacies (JSE:DCP) has a Other Current Receivables of R1,817 Mil as of Feb. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Dis-Chem Pharmacies and its competitors.
Is Dis-Chem Pharmacies' Other Current Receivables too high?
Dis-Chem Pharmacies' current Other Current Receivables is R1,817 Mil. Overall, Dis-Chem Pharmacies has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Other Current Receivables compare to competitors?
Dis-Chem Pharmacies' Other Current Receivables of R1,817 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Dis-Chem Pharmacies and its competitors. Dis-Chem Pharmacies's current Other Current Receivables is R1,817 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.25, compared to a current price of R32.20 — trading 15.8% below its estimated fair value. The current Other Current Receivables is R1,817 Mil. Dis-Chem Pharmacies' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Other Current Receivables is R1,817 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?

Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued. The current stock price of R32.20 is trading 15.8% below its estimated GF Value™ of R38.25. GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.

Key valuation signals for JSE:DCP:

  • Other Current Receivables: R1,817 Mil
  • GF Value™: R38.25 vs. price of R32.20 (15.8% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dis-Chem Pharmacies Business Description

Address 23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
85GF Score

Get the complete analysis for JSE:DCP

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R32.20
Price
R38.25
GF Value